In addition to exploring saliva/throat/nasal swab sample types for our existing COVID-19 test, we are also developing tests that can utilize Fluxergy’s first-of-its-kind multimodal technology. We are designing the following tests for the existing Fluxergy Analyzer model. Our product development pipeline includes:
FUTURE COMBINATION TESTS
AND SYNDROMIC PANELS

PCR, Immunochemistry, and Chemistry Fluxergy Card, and Fluxergy Analyzer Mk 13 Prototypes
TESTING MULTIPLE PARAMETERS
ON A SINGLE TEST CARD
Fluxergy is addressing the current bottleneck in point of care testing: Right now, point-of-care testing requires a different analyzer for each kind of test. The Fluxergy Analyzer is being designed to run individual or combination panels for the following test types:
Measuring Multiple Types of Health Parameters at Once Can Potentially:
